About | Moonlight Therapeutics

About us

Our Company

Moonlight Therapeutics is focused on developing therapies for food allergy.

Moonlight's founders are experts in drug delivery, specifically in designing systems to get across the body's barriers so drugs can be delivered effectively to their intended target. Our proprietary skin stamp delivers antigen to the skin's immune cells to protect patients from deadly anaphylactic reactions.

Our Backing

Strong technology backed by public and private funding

Moonlight Therapeutics has received multiple grants from the National Institutes of Health to develop its allergen immunotherapy platform and its first treatment for peanut allergy, MOON101.

We are supported by public and private funds to evaluate MOON101 in our first clinical trial with peanut allergic adults and children.

Join us in stamping out food allergy.

1/4

Meet Mission Control

Our Team

President and CEO, Board Member

Samir Patel, PhD

Engineer and entrepreneur. Co-founded Clearside Biomedical and invented the technology behind their first FDA-approved therapy.

Full Profile

COO

Vladimir Zarnitsyn, PhD

Co-founded Clearside Biomedical. Holds over 20 patents in drug and gene delivery. Now developing microneedle therapy for peanut allergy.

Full Profile

Research Engineer

Bhavana Suresh

Bhavana Suresh is a chemical engineer who has pursued a career at the intersection of healthcare and engineering.

Full Profile

Scientific Founder

Harvinder Gill, PhD

Professor at NC State University. Pioneered coated microneedles for allergy treatment. NIH Director's New Innovator Award. National Academy of Inventors.

Full Profile

Research Engineer

Grace

Grace is a chemical engineer interested in advancing biotechnology to improve patient outcomes.

Full Profile

Our Board

President and CEO, Board Member

Samir Patel, PhD

Engineer and entrepreneur. Co-founded Clearside Biomedical and invented the technology behind their first FDA-approved therapy.

Full Profile

Chair of the Board

Ritu Shah

Biotech executive with two decades of experience. Led four M&A transactions and multiple drug development campaigns.

Full Profile

Independent Board Member

Harold Shlevin, PhD

Former CEO of Galectin Therapeutics and Solvay Pharmaceuticals. Co-founded CIBA Vision Ophthalmics. Led multiple drug approvals.

Full Profile